SocialPicks: The Stock Idea Community

Sign Up | Log In | What is SocialPicks?

The Stock Idea & Analysis Community

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

picks

Sector:

All Sectors

Technology
Services
Financial
Healthcare
Energy Basic Materials
Consumer Cyclical
Capital Goods
Consumer/Non-Cyclical Transportation
Conglomerates
Utilities

November 28

73%

DNDN Cancer Vaccines: Investing Opportunities beyond Dendreon (NASDAQ: DNDN)

Sector: Healthcare > Biotechnology & Drugs

Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space such as Cell Genesys, Favrille, and Genitope; recent advancements and study results are encouraging while Dendreon (NASDAQ: DNDN) awaits a FDA ...

Mike Havrilla

(+1.04% risk: conservative)

Comment

November 26

73%

CLDA BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: LPTN.OB)

Sector: Technology > Scientific & Technical Instr.

The BioMedReports.com research download section has been updated to include PDFs for two recent research reports written by Griffin Securities for Clinical Data (NASDAQ: CLDA) and Lpath, Inc. (OTC: LPTN.OB). Lpath received a buy rating with a $5 per share 12-month price targe...

Mike Havrilla

(+1.04% risk: conservative)

Comment

November 25

N/A

PARD Biotech Stocks - Beware of The Covered Call Trap

Sector: Healthcare > Biotechnology & Drugs

Years ago when I worked in retail brokerage, I knew a broker at another firm, who specialized in pitching covered call plays. He would explain to clients how with covered calls you take your profits upfront and the premium you just collected gives you a nice cushion to the downside. Say you buy...

Ivan Mutaftchiev

(+0.95% risk: conservative)

Comment

November 24

73%

PBIO Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife

Sector: Healthcare > Biotechnology & Drugs

Below are three under the radar stocks from the healthcare sector that I have been following for the past 3-6 months which have upcoming catalysts in the form of expected strategic deals, clinical trial results, and other corporate developments. Click here to check out my <font> kaChing....

Mike Havrilla

(+1.04% risk: conservative)

Comment

N/A

ISIS ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity

Shares of Isis Pharmaceuticals ( ISIS ) dropped about 17% on Tuesday, November 17 to close at $11.12, down from a previous close of $13.40. The selloff was a reaction to Isis and partner Genzyme( GENZ )'s presentation for Mipomersen Phase 3 Trials data for treatment of HoFH during at the America...

Ivan Mutaftchiev

(+0.95% risk: conservative)

1 comment

Get Daily Alerts in

Get free alerts and recommendations from proven top-performing SocialPicks members

Top Rated Stocks in Sector

Symbol	Company Name	Sentiment
BTU	Peabody Energy Corp
OXY	Occidental Petroleum Corp
KFT	Kraft Foods Inc.
NOV	National Oilwell Varco Inc
T	AT&T Inc
CVX	Chevron Corp
FWLT	Foster Wheeler Ltd.
FMCN	Focus Media Holding Ltd

View All Stock Ratings »

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.